Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'CCKB ANTAGONIST' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 23 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Belzung, C; Le Guisquet, AM; Barreau, S; Calatayud, F
      An investigation of the mechanisms responsible for acute fluoxetine-induced anxiogenic-like effects in mice

      BEHAVIOURAL PHARMACOLOGY
    2. Jetty, PV; Charney, DS; Goddard, AW
      Neurobiology of generalized anxiety disorder

      PSYCHIATRIC CLINICS OF NORTH AMERICA
    3. Coudore-Civiale, MA; Courteix, C; Fialip, J; Boucher, M; Eschalier, A
      Spinal effect of the cholecystokinin-B receptor antagonist CI-988 on hyperalgesia, allodynia and morphine-induced analgesia in diabetic and mononeuropathic rats

      PAIN
    4. Friedrich, AE; Gebhart, GF
      Effects of spinal cholecystokinin receptor antagonists on morphine antinociception in a model of visceral pain in the rat

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    5. Hutcheson, DM; Subhan, F; Pache, DM; Maldonado, R; Fournie-Zaluski, MC; Roques, BP; Sewell, RDE
      Analgesic doses of the enkephalin degrading enzyme inhibitor RB 120 do nothave discriminative stimulus properties

      EUROPEAN JOURNAL OF PHARMACOLOGY
    6. Subhan, F; Pache, DM; Sewell, RDE
      Potentiation of opioid-induced conditioned place preference by the selective serotonin reuptake inhibitor fluoxetine

      EUROPEAN JOURNAL OF PHARMACOLOGY
    7. Makovec, F; Revel, L; Letari, O; Mennuni, L; Impicciatore, M
      Characterization of antisecretory and antiulcer activity of CR 2945, a newpotent and selective gastrin/CCKB receptor antagonist

      EUROPEAN JOURNAL OF PHARMACOLOGY
    8. Little, HJ; Butterworth, AR; O'Callaghan, MJ; Wilson, J; Cole, J; Watson, WP
      Low alcohol preference among the "high alcohol preference" C57 strain of mice; preference increased by saline injections

      PSYCHOPHARMACOLOGY
    9. PERROT S; IDANPAANHEIKKILA JJ; GUILBAUD G; KAYSER V
      THE ENHANCEMENT OF MORPHINE ANTINOCICEPTION BY A CCKB RECEPTOR ANTAGONIST IN THE RAT DEPENDS ON THE PHASE OF INFLAMMATION AND THE INTENSITYOF CARRAGEENAN-INDUCED HYPERALGESIA

      Pain
    10. VALVERDE O; ROQUES BP
      CHOLECYSTOKININ MODULATES THE AVERSIVE COMPONENT OF MORPHINE-WITHDRAWAL SYNDROME IN RATS

      Neuroscience letters
    11. IDANPAANHEIKKILA JJ; PERROT S; GUILBAUD G; KAYSER V
      IN MONONEUROPATHIC RATS, THE ENHANCEMENT OF MORPHINE ANTINOCICEPTION BY L-365,260, A SELECTIVE CCKB RECEPTOR ANTAGONIST, DEPENDS ON THE DOSE OF SYSTEMIC MORPHINE AND STIMULUS CHARACTERISTICS

      European journal of pharmacology
    12. DING XQ; LINDSTROM E; HAKANSON R
      TIME-COURSE OF DEACTIVATION OF RAT STOMACH ECL CELLS FOLLOWING CHOLECYSTOKININ(B) GASTRIN RECEPTOR BLOCKADE/

      British Journal of Pharmacology
    13. VALVERDE O; SMADJA C; ROQUES BP; MALDONADO R
      THE ATTENUATION OF MORPHINE-CONDITIONED PLACE PREFERENCE FOLLOWING CHRONIC MILD STRESS IS REVERSED BY A CCKB RECEPTOR ANTAGONIST

      Psychopharmacology
    14. VANMEGEN HJGM; WESTENBERG HGM; DENBOER JA; SLAAP B; VANESRADHAKISHUN F; PANDE AC
      THE CHOLECYSTOKININ-B RECEPTOR ANTAGONIST CI-988 FAILED TO AFFECT CCK-4 INDUCED SYMPTOMS IN PANIC DISORDER PATIENTS

      Psychopharmacology
    15. LIN JH; STOREY DE; CHEN IW; XU X
      IMPROVED ORAL ABSORPTION OF L-365-260, A POORLY SOLUBLE DRUG

      Biopharmaceutics & drug disposition
    16. HERNANDO F; FUENTES JA; FOURNIEZALUSKI MC; ROQUES BP; RUIZGAYO M
      ANTIDEPRESSANT-LIKE EFFECTS OF CCKB RECEPTOR ANTAGONISTS - INVOLVEMENT OF THE OPIOID SYSTEM

      European journal of pharmacology
    17. LETARI O; MENNUNI L; REVEL L; COLOMBO S; MAKOVEC F
      CYTOSOLIC CA2-CELLS - A NOVEL METHOD TO SCREEN GASTRIN RECEPTOR ANTAGONISTS( EVALUATION IN RABBIT PARIETAL)

      European journal of pharmacology
    18. VALVERDE O; FOURNIEZALUSKI MC; ROQUES BP; MALDONADO R
      THE CCKB ANTAGONIST PD-134,308 FACILITATES REWARDING EFFECTS OF ENDOGENOUS ENKEPHALINS BUT DOES NOT INDUCE PLACE PREFERENCE IN RATS

      Psychopharmacology
    19. JOSSELYN SA; VACCARINO FJ
      INTERACTION OF CCKB RECEPTORS WITH AMPHETAMINE IN RESPONDING FOR CONDITIONED REWARDS

      Peptides
    20. VALVERDE O; BLOMMAERT AGS; FOURNIEZALUSKI MC; ROQUES BP; MALDONADO R
      WEAK TOLERANCE TO THE ANTINOCICEPTIVE EFFECT INDUCED BY THE ASSOCIATION OF A PEPTIDASE INHIBITOR AND A CCKB RECEPTOR ANTAGONIST

      European journal of pharmacology
    21. NOBLE F; BLOMMAERT A; FOURNIEZALUSKI MC; ROQUES BP
      A SELECTIVE CCKB RECEPTOR ANTAGONIST POTENTIATES MU-OPIOID, BUT NOT DELTA-OPIOID RECEPTOR-MEDIATED ANTINOCICEPTION IN THE FORMALIN TEST

      European journal of pharmacology
    22. SAITA Y; YAZAWA H; HONMA Y; NISHIDA A; MIYATA K; HONDA K
      CHARACTERIZATION OF YM022 - ITS CCK(B) GASTRIN RECEPTOR-BINDING PROFILE AND ANTAGONISM TO CCK-8-INDUCED CA2+ MOBILIZATION/

      European journal of pharmacology. Molecular pharmacology section
    23. PATEL S; CHAPMAN KL; HEALD A; SMITH AJ; FREEDMAN SB
      MEASUREMENT OF CENTRAL-NERVOUS-SYSTEM ACTIVITY OF SYSTEMICALLY ADMINISTERED CCKB RECEPTOR ANTAGONISTS BY EX-VIVO BINDING

      European journal of pharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 19/02/20 alle ore 02:21:03